{"prompt": "['MCW', 'OUTPATIENT', 'CPX-351', 'TRIAL', 'STUDY SCHEMA', 'Run-In Phase: Six subjects, enrolled according to monitoring/stopping rules (refer to section 9.4).', 'Continuation Phase: After DSMC safety assessment of the run-in phase, the DSMC approves or denies continued enrollment', 'of', '114', 'subjects in the multi-institution continuation phase.', 'Nurse Teacher', 'Consent*', 'Central Eligibility', 'Outpatient induction with', 'Education Program', 'Confirmation', 'CPX-351 per package insert', 'Subject followed as an', 'outpatient*', 'Outcomes assessed', '* Both subject and caregiver undergo the consent process. Each site implements a study-specific Nurse Teacher Education Program for all', 'consenting subjects and caregivers. Quality of life surveys are obtained from the subject and primary caregiver at baseline, days 7-10,', 'day', '30,', 'day', '60 (+/- 5 days).', '** Prespecified pattern of monitoring applied (refer to Study Calendar of Events). Subjects are admitted/readmitted according to section 5.', 'MCW Protocol No: IIT-Michaelis-OutpatientCPX-351', 'p9', 'Version No.: 3', 'Version Date: 04/15/2020']['MCW', 'OUTPATIENT', 'CPX-351', 'TRIAL', 'STUDY CALENDAR OF EVENTS', 'Induction Therapy', 'Thrice', 'Weekly', 'Once', 'Day 30,', 'Follow Up6', 'Screening\u00b9', 'Until', 'Weekly', 'Day 60', 'Procedure', '(-7 days)', 'Day', 'Day', 'Day', 'Day', 'Day', 'Day', 'Count', 'Until Count', '(Day 90 5', '(from Day', '1 13', '2', '3', '4', '5', '6', 'Recovery', 'Recovery9', '1) 5 Days', 'days)', '9', 'Informed consent', 'X', 'Survival status', 'X', 'Medical/Leukemia History', 'X', 'Physical Exam: MD or APP', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Oncology Nurse Assessment', 'X', 'X', '(in clinic)', 'Oncology Nurse Assessment', 'X', 'X', 'See footnote 5', '(phone call to subject) 5', 'Vitals Signs (in clinic)', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'ECOG Status or Karnofsky', 'X', 'X', 'X', 'Performance Status', 'Hematology7', 'X', 'X', 'X', 'X', 'X', 'Comprehensive Metabolic Panel', 'X', 'X', 'X', 'X', 'X', 'X', '(CMP) 7', 'Urinalysis', 'X', 'Pregnancy test (serum or urine)', 'X', '12', 'Bone Marrow Biopsy and/or', 'Aspirate and/or pathologic', 'confirmation of AML (meeting', 'X', 'eligibility criteria) from', 'peripheral blood smear', 'Echocardiogram or MUGA', 'X', 'Hospitalization Tracking2', 'Day 1 through end of treatment10', 'X\u00b2', 'MCW Protocol No: IIT-Michaelis-OutpatientCPX-351', 'p10', 'Version No.: 3', 'Version Date: 04/15/2020']['MCW', 'OUTPATIENT', 'CPX-351', 'TRIAL', 'Induction Therapy', 'Thrice', 'Weekly', 'Once', 'Day 30,', 'Screening\u00b9', 'Until', 'Day 60', 'Follow Up6', 'Weekly', 'Procedure', '(-7 days)', 'Day', 'Day', 'Day', 'Day', 'Day', 'Day', 'Count', 'Until Count', '(Day 90 5', '(from Day', '1 13', '2', '3', '4', '5', '6', 'Recovery9', 'days)', 'Recovery', '1) 5 Days', '9', 'Transfusion Tracking\u00b3', 'Day 1 through end of treatment10', 'Intravenous Antimicrobial', 'Therapy and Growth Factor', 'Day 1 through end of treatment10', 'Tracking4', 'Cytogenetics', 'X', 'Adverse Events', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'X', 'Concomitant Medications', 'X', 'X', 'X', 'Prophylactics: Antimicrobials', 'X', 'Tumor Lysis prophylaxis', 'X', 'Day 30 ( 5', 'Once', 'QOL Surveys: Subject and', 'days) and', 'X', 'between', 'Caregiver', 'Day 60 ( 5', 'day 7-10', 'days)', 'Central Eligibility Confirmation', 'X', 'Nurse Teacher Education', 'X', 'Program', 'Study Diary8', 'Day 1 through end of treatment10', 'Drug Administration', 'Liposomal daunorubicin/cytarabine (CPX-', 'X', 'X', 'X', '351) 11', 'MCW Protocol No: IIT-Michaelis-OutpatientCPX-351', 'p11', 'Version No.: 3', 'Version Date: 04/15/2020']\n\n###\n\n", "completion": "END"}